<DOC>
	<DOC>NCT02689934</DOC>
	<brief_summary>A randomized, double-blind, placebo-controlled, parallel study to evaluate the efficacy of a red yeast rice based nutraceutical (monacolin K 10 mg/dose) plus probiotic (Bifidobacterium longum BB536 ®), versus placebo, in patients with moderate hypercholesterolemia, in terms of improvement of the lipid profile and cardiovascular risk.</brief_summary>
	<brief_title>Efficacy of a Red Yeast Rice Based Nutraceutical Plus Probiotic in Patients With Moderate Hypercholesterolemia</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Red yeast rice</mesh_term>
	<mesh_term>Lovastatin</mesh_term>
	<mesh_term>L 647318</mesh_term>
	<mesh_term>Dihydromevinolin</mesh_term>
	<criteria>18 ≤ men or women ≤ 70 men or female. Female must be postmenopausal or surgically sterile 130 mg/dl ≤ LDLC ≤ 200 mg/dl patients in primary cardiovascular prevention pregnancy and lactating patients with chronic diseases patients with serious hepatic diseases patients with serious renal diseases patients with thyroid diseases diabetes mellitus or glycemia &gt;126 mg/dl uncontrolled or severe hypertension obesity(BMI&gt;30) smoking status drug or nutraceutical that can interfere with the experimental treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>hypercholesterolemia</keyword>
	<keyword>bifidobacterium longum BB536</keyword>
	<keyword>red yeast rice</keyword>
	<keyword>monacolin K</keyword>
	<keyword>lactoflorene colesterolo</keyword>
</DOC>